• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Osprey Medical

Osprey Medical jumps 8% on news of CE Mark

August 14, 2020 By Sean Whooley

Osprey Medical (ASX:OSP) announced that it received CE Mark approval in Europe for its DyeVert Power XT second-generation device. Upon yesterday’s announcement of the regulatory milestone, shares of OSP jumped up nearly 8.6%. However, today, they are trading down -5.3% at 4¢ per share in mid-afternoon trading. Approval allows Osprey to market and sell its DyeVert […]

Filed Under: Imaging, Regulatory/Compliance Tagged With: CE Mark, GE Healthcare, Osprey Medical

GE to distribute Osprey Medical DyeVert contrast minimization devices

July 31, 2020 By Sean Whooley

GE Healthcare (NYSE:GE) announced that it will exclusively distribute the DyeVert portfolio for imaging technology developer Osprey Medical (ASX:OSP). Osprey’s DyeVert contrast minimization devices align with GE’s iodinated X-ray contrast media to offer a technology platform to address acute kidney injury (AKI) following interventional coronary angiograms in patients with chronic kidney disease (CKD), according to a news […]

Filed Under: Business/Financial News, Distribution, Imaging Tagged With: GE Healthcare, Osprey Medical

Osprey Medical raises $7m, looks to raise $8m in entitlement offer

November 1, 2018 By Fink Densford

Osprey Medical (ASX:OSP) said today that it inked deals that could bring in up to $14.5 million for the company to support continued growth and accelerated commercialization of its product platform. The Minneapolis, Minn.-based company said it inked a $7 million private placement deal with investment management firm Allan Gray for approximately 64.5 million Chess Depository Interests, […]

Filed Under: Business/Financial News Tagged With: Osprey Medical

Osprey Medical raises $18m

August 8, 2017 By Fink Densford

Osprey Medical (ASX:OSP) said today it raised $17.6 million (AUD $22.2 million) from an oversubscribed offering of Chess Depository Interests, and that it is looking to raise an additional $8.2 million (AUD $10.3 million) in an entitlement offer. The Australian company said it floated approximately 55.5 million CDIs, representing 27.7 million shares of common stock, at 32¢ […]

Filed Under: Business/Financial News Tagged With: Osprey Medical

Firms in Minnesota’s Medical Alley raised $117m in Q3

October 13, 2016 By Fink Densford

Firms in Minnesota’s Medical Alley raised $117 million during the 3rd quarter, bringing their total year-to-date funding to $335.8 million, the trade group reported today. Medical Alley, which rebranded from LifeScience Alley in January, reported that 77 companies from the region completed funding rounds in 2016, matching 2015’s numbers between the 1st and 3rd quarters. “Medical Alley continues to […]

Filed Under: Funding Roundup, Wall Street Beat Tagged With: Cogentix Medical, CVRx Inc., Medical Alley, Osprey Medical, rotationmedical, Torax Medical Inc.

Osprey Medical raises $21.3m

August 4, 2016 By Fink Densford

Osprey Medical (ASX:OSP) said it raised $21.3 million (AUD $28 million) through the sale of CHESS depository interests to support the expanded commercialization of its DyVert System and ongoing research and development. The Australian company raised the funds from institutional investors through the sale of 100 million CDIs at 21¢ (AUD 28¢) per CDI, set […]

Filed Under: Business/Financial News, Imaging Tagged With: Osprey Medical

Osprey Medical dives on failed trial despite FDA wins

October 19, 2015 By Brad Perriello

Australian investors, reacting today to news that Osprey Medical (ASX:OSP) failed to meet a key endpoint in a clinical trial, took OSP shares down by some -55% today. The plunge came despite news that the FDA approved expanded claims for Osprey’s Avert device, which is designed to reduce and monitor the amount of contrast agent injected […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Imaging, Regulatory/Compliance, Wall Street Beat Tagged With: Osprey Medical

Osprey rises on FDA 510(k) for DyeVert

October 12, 2015 By Fink Densford

Osprey Medical (ASX:OSP) said it received FDA 510(k) clearance for its DyeVert contrast modulation system, sending shares of the company to a nearly 2-month high. The DyeVert system automates contrast modulation during manual dye injections, self adjusting for catheter and contrast types without requiring user adjustments, Osprey said. “With FDA Clearance of our DyeVert System, […]

Filed Under: 510(k), Catheters, Food & Drug Administration (FDA), Regulatory/Compliance, Vascular Tagged With: Osprey Medical

Medtech investment in MN falls back to earth | Medtech funding for the week of April 20, 2015

April 24, 2015 By MassDevice Leave a Comment

Medtech investment in Minnesota falls back to earth

April 17, 2015 by Scott Wooldridge

Filed Under: Funding Roundup, News Well Tagged With: Aisling Capital, Aperture Venture Partners, Correlation Ventures, CSA Medical Inc., Medical Alley, Osprey Medical, PureTech, Spirox, Sunshine Heart Inc., Tal Medical, Venrock, Western Technology Investment

Medtech investment in Minnesota falls back to earth

April 17, 2015 By Scott Wooldridge Leave a Comment

Medtech investment in Minnesota falls back to earth

After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley.

Filed Under: Funding Roundup, News Well Tagged With: Medical Alley, Minnesota, Osprey Medical, Sunshine Heart Inc.

OSP fishes up $11m | Medtech funding for the week of March 23, 2015

March 27, 2015 By MassDevice Leave a Comment

Osprey Medical fishes up $11m private placement

March 24, 2015 by Brad Perriello

Filed Under: Funding Roundup, News Well Tagged With: Harvard University, Orthosensor Inc., Osprey Medical, Semma Therapeutics

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS